We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you
are consenting to our use of cookies.

Could new discovery play a role in diagnosing Alzheimer’s earlier?

Discovered in mice and confirmed in human samples, scientific team become the first to observe how a characteristic of the Presenilin1 gene means it could be used as a biomarker for Alzheimer’s

Peer reviewed / Observational study / Animals, Cells

Scientists have detected that a previously overlooked gene behavior could potentially lead to a new way to diagnose Alzheimer’s earlier.

Published in the journal Epigenetics, an international research team’s findings – discovered in mice and confirmed in human samples – suggest that the gene Presenilin1 (PSEN1) should be monitored as a ‘biomarker’: to see what environmental triggers, such as lifestyle and nutrition, can influence brain function and neurodegeneration or/and to see how well the body responds to a treatment for the disease.

Led by Professor Andrea Fuso at the Sapienza University of Rome, the study is the first to observe that the methylation (when the DNA activity of a gene can change, without changing the actual DNA sequence) of the gene PSEN1 is a common feature of Alzheimer’s.

The results of the study appear to show that PSEN1, which was already known to behave differently for people with Alzheimer’s, may have been dismissed in previous studies due to methods used to investigate DNA methylation.

The limitations of comparing results from mouse models and humans include, mouse stages of development and neurodegeneration not corresponding precisely to those of human aging. In this study, the team note that the blood and brain samples were obtained from different subjects. They suggest that future studies should analyse DNA from the same individuals, and in a larger cohort, in order to validate this potential biomarker.

However, Professor Fuso, from the Department of Experimental Medicine, at Sapienza University of Rome, states that the new results do offer “an exciting new area of investigation”.

“We’ve detected an early sign of the disease in a DNA modification, or epigenetic marker, that was previously overlooked, and that could even provide a starting point for developing new therapies, as well as earlier diagnosis” he added.

Worldwide, nearly 50 million people have Alzheimer’s or related dementia. Yet, only 1-in-4 people with Alzheimer’s disease have been diagnosed.

The earlier Alzheimer’s can be detected, the better the chance of using treatment to delay the onset of severe dementia. Epigenetic alternations to genes, induced by environmental triggers such as lifestyle and nutrition, can influence brain function and neurodegeneration. Evidence from animal models has found that changes to regulation of the PSEN1 gene is associated with Alzheimer’s-like pathology, but only a handful of studies have investigated DNA modification of the gene in humans.

For the current study, the authors analysed patterns of DNA modification that affect the expression of the PSEN1 gene during brain development and during the progression of Alzheimer’s in mice. They checked the results in humans by analysing post-mortem human brain tissue from Alzheimer’s patients and from prenatal and postnatal babies and adolescents. To see whether changes to DNA methylation could be detected in human blood, they analysed blood samples from 20 patients with late-onset Alzheimer’s disease, comparing the results to 20 healthy controls.

In Alzheimer’s-prone mice of both sexes, they found that the PSEN1 gene was overexpressed. In adult female mice only, this overexpression was associated with lower DNA methylation. The results from post-mortem human brain tissue found upregulation of the PSEN1 gene in Alzheimer’s patients. In both sexes, there was a significant inverse relationship between the extent of gene expression and DNA methylation. The fact that sex-specific differences were not found in human tissue could be due to the relatively small sample size.

“Differences between the sexes in DNA modifications would be extremely interesting to researchers working to better understand Alzheimer’s disease and to develop new therapies,” says Professor Fuso.

The analysis of blood samples was able to detect lower PSEN1-related DNA methylation in Alzheimer’s patients compared to controls. The difference was significant, although not as large as in brain samples. As lower methylation was detectable in the blood, and is associated with higher expression of PSEN1, it could offer a new way to diagnose Alzheimer’s early, and less invasively, than sampling brain tissue.

Professor Fuso concludes: “Our results offer an exciting new area of investigation, deploying the methods we used to study DNA methylation so that modifications won’t be missed. If found to be causal, our findings would provide a starting point for developing epigenetic therapies.”

FURTHER INFORMATION

The study was funded by the European Commission, the Spanish Ministry of Health and the Italian Ministry of Health.

About Taylor & Francis GroupTaylor & Francis Group partners with researchers, scholarly societies, universities and libraries worldwide to bring knowledge to life. As one of the world’s leading publishers of scholarly journals, books, ebooks and reference works our content spans all areas of Humanities, Social Sciences, Behavioural Sciences, Science, Technology and Medicine.

Books contacts

A 425-million-year-old millipede fossil found in Scotland is the world's oldest known fossil of an insect or arachnid. Researchers have published their exciting new findings in Historical Biology [Read more...]

3

1

3 days ago

We are excited to announce have integrated into their #manuscriptsubmission processes with . More here: [Read more...]

0

0

5 days ago

Does #pregnancy affect #memory? This article, in the news, compared control participants with those in their third trimester of pregnancy to find out... #Neuropsychology [Read more...]

1

2

9 days ago

What can modern scientists, looking for a #COVID19 vaccine, learn from Edward Jenner? This article looks at the history of smallpox
and vaccination
[Read more...]

0

1

9 days ago

How will #sports be after #COVID19? This article examines role of the media and how it affects sports #socialmedia #golf [Read more...]

2

0

10 days ago

A recent study of people in Singapore who had contracted SARS in the early aughts found they retain “significant levels of neutralizing antibodies” for nine to 17 years after initial infection [Read more...]

0

0

11 days ago

This study found that shields worn by a test subject within 1.8 metres of a cough reduced inhaled influenza virus by 92%, although this protective effect reduced after the cough had dispersed for 30 minutes [Read more...]

2

0

17 days ago

This new research shows that people believe they're less likely than others are to fall for online scams. The cybersecurity study has significant implications as we increasingly work remotely during #COVID19 pandemic [Read more...]

0

1

17 days ago

The number of Asian Hornets, Vespa mandarinia, is on the rise in North America. This study shows just how potentially lethal they are with 30 to 50 people dying each year in Japan alone [Read more...]

0

0

18 days ago

Looking at 315,000 children, this new study out today suggests that childhood obesity raises bladder cancer risk. The findings could help scientists improve their understanding of what triggers bladder cancer [Read more...]